Dr. Baliga's 'Podkasts for Curious Docs'
๐ง John Locke: Experience โข Liberty โข Toleration Born a physician-philosopher, Locke championed empiricism โ the idea that knowledge begins with experience, not dogma. His tabula rasa shaped modern psychology, while his Two Treatises of Government defined rights, consent, and freedom that echo through modern democracies. For clinicians, his legacy reminds us to: ๐น Trust observation and evidence over authority ๐น Respect patient autonomy and informed consent ๐น Foster pluralism and toleration in care His vision of reason and tolerance remains medicineโs...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
๐ VESALIUS-CV delivers powerful evidence: in high-risk patients without prior MI or stroke, evolocumab significantly reduced 3-point MACE by 25% and 4-point MACE by 19%, with LDL-C lowered to a median of 45 mg/dL. ๐ก These results expand the horizon of prevention, showing that deep LDL reduction is both safe and effective in averting first cardiovascular events. ๐ซ Strong science. Clear signal. A new chapter in preventive cardiology. #Cardiology #LDL #Prevention #VESALIUSCV
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
๐ซ Septic Shock, Refined at the Fingertips โฑ๏ธ A powerful new JAMA (2025) trial brings us one step closer to truly personalized resuscitation. The ANDROMEDA-SHOCK-2 study shows that targeting capillary refill time (CRT) โ a simple bedside sign โ can shorten time on organ support vs usual care, without increasing mortality. Key insight: Sometimes the most elegant solutions are low-tech, high-touch, and right at the bedside. ๐ง Precision ๐ค Physiology ๐ก Pragmatism #Sepsis #CriticalCare #PersonalizedMedicine #JAMA #Hemodynamics #ICU #Shock
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
๐จ SOFA-2 arrives โ a thoughtful evolution in critical care scoring ๐ง ๐ซ๐ซ After nearly 30 years, the SOFA score has been modernized using data from >3.3 million ICU patients across 9 countries. The updated SOFA-2 incorporates contemporary respiratory and cardiovascular supports (HFNC, NIPPV, vasopressors, ECMO) and refines thresholds while preserving simplicity and bedside usability. A meaningful step forward in describing organ dysfunction โ with room for future biologically grounded refinement. ๐ Published in JAMA
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
SOFA-2 is here โ a major advance in assessing organ dysfunction in critical illness ๐ง ๐ซโค๏ธ Three decades after the original SOFA score, this updated framework reflects modern ICU practice โ integrating contemporary organ support (ventilation, vasopressors, RRT), delirium recognition, and global feasibility across resource settings ๐๐ Validated in 3.3M+ ICU patients across 9 countries โ a remarkable effort in global critical care science ๐ฅ๐ A powerful step forward in our shared language of severity and recovery. ๐ JAMA Network Open, 2025
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
๐ Peripartum Cardiomyopathy: When a Motherโs Heart Fights for Two Peripartum cardiomyopathy is a leading yet often missed cause of maternal morbidity and mortalityโstriking late in pregnancy or months postpartum. Early suspicion, timely echo, and guideline-directed therapy save lives. ๐ฉบ ๐ง Bromocriptine, careful anticoagulation, and multidisciplinary care are reshaping outcomes, but global disparities persist. ๐ Letโs amplify awareness, strengthen systems, and protect mothers everywhere. ๐คโค๏ธ #HeartFailure #MaternalHealth #Cardiology...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
Rethinking โdefault linesโ in the ICU ๐ง ๐ A landmark NEJM trial shows that in patients with shock, deferring arterial catheterization and using automated cuff monitoring was noninferior for 28-day mortality โ and reduced catheter-related complications. A gentle reminder: not every sick patient needs a needle to be well cared for. Precision isnโt only invasive โ sometimes itโs thoughtful, measured, humane. ๐ฟ๐ก #CriticalCare #ICU #NEJM #Shock #Hemodynamics #PatientSafety
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
๐ Bright Nights, Higher Heart Risk โค๏ธโ๐ฉน New findings in JAMA Network Open highlight that greater exposure to artificial light at night is associated with significantly increased risks of coronary artery disease, myocardial infarction, heart failure, atrial fibrillation, and stroke โ independent of sleep duration, lifestyle factors, and genetics. ๐ก Clinical takeaway: Protecting circadian rhythms is cardiovascular prevention. Darker nights = healthier hearts. ๐ Simple steps: blackout curtains, limit screens before bed, use warm/dim evening lighting....
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
The immune clock starts earlier than we think โณ๐งฌ A landmark Nature study shows that immune aging begins quietly in midlife โ decades before clinical frailty. Using >16M single-cell profiles and longitudinal vaccine responses, researchers found: โข Stable, early transcriptional drift in naรฏve & memory T cells โข A subtle TH2 shift that may weaken antiviral antibody quality โข Reduced IgG class-switching to repeat flu antigens (e.g., B/Phuket) โข No acceleration from CMV infection despite compositional shifts The message? Immune aging is gradual, not...
info_outlineDr. Baliga's 'Podkasts for Curious Docs'
๐ซ TAVR or SAVR? The 7-Year Truth New 7-year results from the PARTNER-3 trial (NEJM) show that in low-risk patients with severe symptomatic aortic stenosis, TAVR holds pace with surgery โ delivering comparable survival, stroke rates, rehospitalization, valve durability, and quality-of-life outcomes. ๐ Highlights โข Composite events: 34.6% (TAVR) vs 37.2% (SAVR) โข Mortality: 19.5% vs 16.8% โข Valve failure: 6.9% vs 7.3% โข Aortic gradients remain low in both groups ๐ก Clinical rhythm: less AF with TAVR; more pacemakers and paravalvular leak. This study...
info_outline๐จ Just read the latest Lancet 2025 Seminar on Large-Vessel Vasculitis โ a must-read for anyone tracking ๐ Giant Cell Arteritis, ๐ฅ Takayasu Arteritis, and ๐งฌ Isolated Aortitis. From ๐ clinical phenotypes to ๐ง imaging advances and ๐ฏ targeted biologics like tocilizumab and JAK inhibitors, this article bridges inflammation with innovation.
๐ธ Vascular imaging, ๐ฌ immunopathology, and ๐งช new therapiesโessential insights for rheumatology, cardiology & internal medicine teams.
๐ Read it, teach it, share it! #Vasculitis #GCA #TAK #Immunology #PrecisionMedicine #Lancet2025